CNE000000Q45
CNE000000Q45
APELOA PHARMA.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 9.783.600.915 | 12.021.863.029 | 18.6% |
| Cost of Revenue | 7.204.943.429 | 9.155.202.968 | 21.3% |
| Gross Profit | 2.578.657.486 | 2.866.660.061 | 10.0% |
| 1.511.931.519 | 1.690.605.760 | 10.6% | |
| Operating Income | 1.066.725.967 | 1.176.054.301 | 9.3% |
| Pretax Income | 1.066.198.869 | 1.203.290.373 | 11.4% |
| Net Income Common Stockholders | 890.677.997 | 1.031.121.699 | 13.6% |
| -- | -- | -- | |
| -- | -- | -- |